Dose Finding Study of CHF 4226 for Treating Patients With COPD

NCT00605891 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

278

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: carmoterol (CHF 4226)
DRUG: carmoterol (CHF 4226)
DRUG: carmoterol (CHF 4226)
DRUG: salmeterol
DRUG: placebo

Sponsor

Chiesi Farmaceutici S.p.A.

Collaborators

[object Object]